Literature DB >> 3579612

Enhanced antibody responses in mice by combined administration of interferon with rabies vaccine.

K Mifune, K Mannen, S Cho, H Narahara.   

Abstract

Exogenous interferon administered to mice at the time of, and 6 hours after the first dose of 3 daily vaccinations accelerated and enhanced the IgM and IgG antibody responses to rabies virus. The effect of interferon was not evident when the interferon was administered later in the vaccination schedules and was abrogated by prior administration of anti-interferon antibody to the mice. The number of IgM antibody secreting cells in the spleen was significantly greater in mice treated with interferon than in controls.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579612     DOI: 10.1007/bf01310721

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration.

Authors:  G M Baer; P A Yager
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  Role of interferon induction in the protective activity of rabies vaccines.

Authors:  T J Wiktor; B Postic; M Ho; H Koprowski
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

3.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

4.  Functional and morphologic characteristics of interferon-treated macrophages.

Authors:  R M Schultz; M A Chirigos; U I Heine
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

5.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

6.  Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

7.  A mouse model of the pathogenesis and postexposure prophylaxis of rabies.

Authors:  K Mifune; A Shichijo; Y Makino; E Takeuchi; A Yamada; K Sakamoto
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

8.  Further studies on rabies postexposure prophylaxis in mice: a comparison of vaccine with interferon and vaccine.

Authors:  J A Moreno; S D Baughcum; H B Levy; G M Baer
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

9.  Interferon preparations enhance phagocytosis in vivo.

Authors:  R M Donahoe; K Y Huang
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

10.  Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.

Authors:  B Härfast; J R Huddlestone; P Casali; T C Merigan; M B Oldstone
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

View more
  3 in total

1.  A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects.

Authors:  H X Lin; C Gontier; M F Saron; P Perrin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.

Authors:  M De Franco; S Massa; R C Vassão; M Siqueira; O A Sant'Anna
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.

Authors:  I Gresser; C Carnaud; C Maury; A Sala; P Eid; D Woodrow; M T Maunoury; F Belardelli
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.